BANNOCKBURN, Ill. (PRWEB) August 20, 2010 -- Advanced Clinical introduces the“Industry Leading R&D Performance” (ILRDP) framework. Using ILRDP, Advanced Clinical will create significant, sustainable efficiencies and effectiveness in research and development, as well as accelerate clinical trials for Life Sciences clients.
ILRDP employs codified delivery methods, tools, techniques and intellectual property assets to speed the delivery of a clinical trial at the lowest Total Cost of Ownership and with the highest probability of success.
"Using ILRDP as a foundational framework, Advanced Clinical has augmented its offerings and capabilities to be able to help Life Sciences companies with strategic effectiveness, as well as improve efficiencies in clinical development, planning and operations. Our goal is to make a positive, sustainable net profit impact for our clients,” said Leo Sheridan, CEO of Advanced Clinical.
Rosemarie Truman, Executive Vice President, Solutions and Thought Leader of ILRDP, added, “Among the several other diagnostic elements, our ILRDP model evaluates known risks for every part of a clinical trial and provides associated mitigation techniques for those risks. The model is proven to create breakthrough results in nearly every industry sector by injecting leading practices into the right areas of the business. Advanced Clinical can now provide an end-to-end solution to ensure a successful trial.”
About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, “One Team” approach. To learn more, visit http://www.advancedclinical.com.
1200 Lakeside Drive
Bannockburn, IL 60015